Injectable

Kenya has initiated a phased rollout of Lenacapavir, a long-acting injectable medicine for HIV prevention. The government’s action marks a significant advancement in the nation’s public health strategy and places Kenya among nine African countries pioneering this innovation. The introduction of Lenacapavir aims to address challenges associated with daily oral pre-exposure prophylaxis (PrEP), including stigma […]